NCT02279966View on ClinicalTrials.gov

Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine 10 mg

DRUG

Paroxetine 20 mg

DRUG

Placebo

Trial Locations (18)

Unknown

EE001, Tallinn

EE002, Tallinn

EE004, Võru

FI002, Helsinki

FI003, Helsinki

FI001, Kuopio

FI008, Oulu

FI007, Tampere

DE002, Berlin

DE001, Bielefeld

DE003, Frankfurt

DE007, Frankfurt

DE008, Schwerin

LT002, Kaunas

LT006, Palanga

LT003, Šilutė

LT001, Vilnius

LT005, Vilnius

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02279966 - Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter